Setmelanotide

Sedmelanotide

Sedmelanotide

ʻO Setmelanotide kahi cyclic octapeptide derivative a me ka hanauna e hiki mai ana a me ka melanocortin-4 receptor agonist koho..

Pane wikiwiki

ʻO ka peptide Setmelanotide hilinaʻi i hāʻawi ʻia e ka mea hana loea a me ka hale hana. Hāʻawi i nā peptides RM-493 maʻemaʻe kiʻekiʻe no ka endocrine, nā papahana noiʻi biomedical maʻi diabetes a me ka metabolism.

SKU: 198911 Māhele:
Kaʻana like i kāu aloha

Sedmelanotide (inoa inoa Imcivree®) he cyclic octapeptide derivative a me ka hanauna e hiki mai ana a koho melanocortin-4 receptor agonist. ʻO ka melanocortin-4 receptor he ʻāpana koʻikoʻi o ka ʻōnaehana nerve waena ikehu homeostasis pūnaewele hoʻoponopono.

Ua like ka hana a Setmelanotide endogenous kanaka melanocortins (e like me α-melanocyte stimulating hormone, α-MSH), akā ua hoʻomohala ʻia e lilo i mea ikaika loa, koho a me ka metabolically kūpaʻa ma mua o ke kūlohelohe ligand.

Hōʻike haʻahaʻa loa EC50 (ka hapalua o ka nui o na manao kupono) no ke kanaka a me ka iole MC4R–0.27 nM a 0.28 nM pakahi, no laila e hōʻike ana i kona kiʻekiʻe kiʻekiʻe o ka receptor hoʻāla mana.

Hoʻoulu ʻo Setmelanotide i ka intracellular kAMP hōʻailona ma o ka hoʻoulu ʻana o nā mea hoʻokipa melanocortin-4 i loaʻa i nā ʻāpana like ʻole o ka lolo, me ka hypothalamus, a no laila hoʻoponopono i ka ʻai, ka hoʻolilo ʻana i ka ikehu a me ka hana puʻupuʻu autonomic me ka hoʻololi ʻana i ke kahe o ke koko ma o ka hoʻoulu ʻana i nā neurons preganglionic o ka ʻōnaeʻa puʻuwai aloha.

Ma muli o kona ʻoi aku ka maikaʻi o ka hoʻopaʻa ʻana i nā mea hoʻopili, lawelawe ia ma ke ʻano he mea hana waiwai no nā haʻawina o MC4R-nā mea hoʻohuihui protein (e.g., MRAP2) ka launa pū ʻana.

Ma nā hoʻonohonoho lāʻau lapaʻau, Ua unuhi maikaʻi ʻia ʻo Setmelanotide i kahi lāʻau lapaʻau e pili ana i ka mālama ʻana i nā maʻi obesity genetic i loaʻa mai nā hemahema i ke ala leptin-melanocortin..

Hoʻololi ia i ka loaʻa kaumaha o ka lāʻau (e.g., risperidone), Loaʻa iā ia nā hopena anti-inflammatory astrocytes, a hiki ke hana synergistically me nā hana metabolic e like me kaohi caloric-ʻo ia mau mea a pau e hōʻike ana i kona waiwai ʻepekema kiʻekiʻe a hiki ke hoʻohana ʻia i nā kahua noiʻi ʻē aʻe (e like me ka momona, metabolic syndrome a nā maʻi neuroendocrine).

Kaʻina

Ac-Arg-Cys-{d-Ala}-Kona-Phe-Arg-Trp-Cys-NH2 (Alahaka disulfide:Kiekie2-Kiekie8)

Helu CAS

920014-72-8

ʻĀpana Molekala

C₄₉H₆₈N₁₈O₉S₂

Kaumaha Molekala

694.91

Noiʻi o Setmelanotide
1.MC4R Pathway a me ka MOA o Setmelanotide

ʻO MC4R kahi ʻO ka mea hoʻokipa i hui pū ʻia me ka protein G (GPCR) ʻo ia ka mea i hōʻike nui ʻia i loko o ka ʻōnaehana waena, i loko o kekahi mau nuclei o ka hypothalamus.

Hōʻike kēia mau wahi i nā pūnaewele kumu no ka ʻike ʻana i nā cues metabolic a me ka mālama ʻana i ka ʻano hānai a me ke koena o ka ikehu.

Ma nā kūlana physiological, komo kēia ala MC4R i ka pale ʻana i ka ʻai a me ka hoʻoulu ʻana i ka hoʻolilo ikehu..

Hoʻoulu pinepine ʻia kēia ala e ka α-melanocyte-stimulating hormone (α-MSH, a POMC mea hoʻopuka) hana ʻia e nā neurons POMC i ka nucleus arcuate.

ʻO ka hoʻoulu ʻana o MC4R e α-MSH e hoʻoulu i kahi cascade o nā hōʻailona o lalo e kāohi ai i ka ʻai a me ka ʻai ʻana i ka meaʻai..

Akā inā loaʻa nā hoʻololi i ka gene POMC e pale ai i ka synthesis α-MSH, E ho'omau 'ia ka MC4R no ka mea 'a'ole i loa'a ka ho'oulu 'ia e kona mau ligands endogenous.

Hoʻopilikia kēia hōʻailona i ka pathological, ʻai ʻai ʻole ʻia a me ka momona morbid ma hope.

He mea paʻakikī loa ka ʻike ʻana i ka lāʻau no ke ala MC4R ma mua o Setmelanotide.

Ua loaʻa i nā agonists MC4R koho mua ʻole i nā hopena ʻino ʻole e like me ka pigmentation o ka ʻili a me ka moe kolohe ma o ka hoʻoulu ʻana i nā mea ʻē aʻe. melanocortin receptors (ʻo ia hoʻi., MC1R, MC3R, a me MC5R).

Ua maʻalahi ka pahuhopu hoʻomohala o Setmelanotide: e hoʻokō i ka koho kiʻekiʻe no MC4R e hoʻopaʻa i kona hopena i ka hoʻopau ʻana i ka ʻai a me ka hoʻonui ʻana i ka ikehu a hoʻemi i nā hopena ʻaoʻao e pili ana i ka paʻa ʻana i waho..

ʻO ka hana koʻikoʻi o ka exogenous MC4R agonist Setmelanotide e hana ma ke ʻano he pani no α-MSH, hoʻoulu pololei i ka MC4R i mea e hoʻoponopono ai i ka pathophysiology i luna a hoʻihoʻi i kēia hōʻailona koʻikoʻi no ke kaulike o ka ikehu..

ʻO ka hopena molecular a me ka cellular hopena o Setmelanotide ka mea i unuhi i loko o nā pane physiological systemic hohonu.

Ma ka hoʻoulu ʻana i nā neurons MC4R ma nā wahi koʻikoʻi ma ka lolo e like me ka hypothalamus PVN, Hiki iā Setmelanotide:

Nā haʻawina ʻo Obesity a me Rare Genetic Obesity Syndromes: He mea pono ʻo Setmelanotide i ke aʻo ʻana i ka hana o ke ala MC4R.

ʻOi aku ka ʻike, ua hōʻike ʻia ka maikaʻi i ka mālama ʻana i nā ʻano ʻano ʻano obesity ma muli o ka hemahema o POMC, LEPR a i ʻole PCSK1 a hoʻohuli i ka momona mua loa mai nā hoʻololi ʻana ma ke ala MC4R.

Hana ʻo Setmelanotide e hoʻihoʻi i ka hana o ka hoʻoponopono kaulike o ka ikehu ma o ka hoʻāla ʻana i ke ala MC4R, e alakaʻi ana i ke kaumaha nui, emi ka pololi, a me ka hoʻomaikaʻi ʻana i nā ʻāpana metabolic.

2.Hoʻoponopono i ka hana ʻino

Ua hōʻike ʻia nā haʻawina o Setmelanotide i nā astrocytes e lawelawe ana i kahi hana anti-inflammatory kūikawā.

I ka pro-inflammatory cytokine (TNF-α/IFN-γ)- nā astrocytes i hoʻāla ʻia, Hiki i ka Setmelanotide ke hoʻopau loa i ka hoʻāla ʻana o ke ala hōʻailona NF-κB a hoʻemi i ka huna o ka pro-inflammatory. chemokines (e like me CCL2 a CXCL10).

Ma waho aʻe o ka pale ʻana i ka ʻeha, Hoʻokomo pū ʻo Setmelanotide i nā astrocytes e hūnā i nā cytokines IL-6 a IL-11 hiki ke paipai polarization macrophage i loko o kahi phenotype anti-inflammatory (ʻAno M2).

3.Hoʻonui i ka hoʻolilo ikehu

Ma waho aʻe o ka hōʻemi pololei ʻana i ka ʻai (ʻai), Hoʻokiʻekiʻe pū ʻo Setmelanotide i ka hoʻolimalima ikehu hoʻomaha (REE).

Ua like ia me ka hoʻohuli ʻana i ka hoʻololi metabolic o ke kino, hiki iā ia ke puhi i nā calorie i ka wā hoʻomaha e like me ka hoʻoikaika kino.

Ua hoʻonui nui ʻo Setmelanotide basal metabolic rate (BMR) a me ka lilo ikehu hana (AEA) , e alakaʻi ana i ka hoʻemi wikiwiki ʻana i nā kumu hoʻohālike ʻiole obese (e.g., ka Magel2-null syndrome model).

ʻO ka hanu hanu (RER) emi iho ka holoholona ma hope o ka lapaau ana, e hōʻike ana i ka hoʻololi ʻana o ke kino mai ka carbohydrate i ka momona oxidation, pono no ka hoʻopau ʻana i ke ake a me ka momona i mālama ʻia.

Hoʻomaha hoʻolimalima ikehu (REE) ua hoonuiia e 6.4% me Setmelanotide i kahi haʻawina Phase III e pili ana i nā kumuhana obese olakino, i loko o kahi manawa lapaʻau ʻano pōkole o 72 hola (111 kcal/24 hola).

ʻO kēia ke ʻano o ka puhi ʻana o ke kino o ka mea maʻi i nā calorie keu, me ka hoololi ole i ka ai.

4.Hoʻomaikaʻi ʻia ke Ola Metabolic

ʻAʻole ʻo Setmelanotide i hoʻoiho wale i ke kaumaha akā ua hōʻike pū i ka hoʻohuli ʻana i nā maʻi metabolic pili i ka momona, me ka hepatic steatosis a me pale ʻana i ka insulin.

ʻAʻole hoʻemi ʻia ka paona wale nō ka mālama ʻana iā Setmelanotide, aka, ua hoemi pu i ka momona o ka ate, a me ka poino o ka hepa.

ʻAʻole kēia he hopena o ka pohō kaumaha akā he hoʻonui pololei i ka hana ate.

Me ka like pu, Ua emi nui ka pae o ka insulin hoʻokē ʻai o ka poʻe maʻi me ka hoʻomaikaʻi ʻana i ka pale ʻana o ka insulin, e hōʻike ana i kahi kūlana maikaʻi o ka metabolism glucose.

I ka emi ana o ka momona, pae serum o leptin haule no hoi.

Manaʻo pinepine ʻia kēia he hōʻailona o ke olakino metabolic maikaʻi – no ka mea, ʻoi aku ka nui o nā leptin e hōʻike pinepine ana i ka momona a me ka pale ʻana i ka insulin.

COA

HPLC

MS

Kaʻina:

Ac-Arg-Cys-{d-Ala}-Kona-Phe-Arg-Trp-Cys-NH2 (Alahaka disulfide:Kiekie2-Kiekie8)

CAS:

920014-72-8

M.W:

694.91 g/mol

Home Huli Whatsapp Nā lawelawe Huahana